Hot Products

ONLINE INQUIRY

Porcine Cardiac Fibroblasts

Cat.No.: CSC-C4886L

Species: Pig

Source: Heart

Cell Type: Fibroblast

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4886L
Description
Porcine Cardiac Fibroblasts from Creative Bioarray are isolated from heart tissue of porcine. Porcine Cardiac Fibroblasts are grown in T75 tissue culture flasks pre-coated with gelatin-based coating solution and incubated in Creative Bioarray Complete Growth Medium. The cells are shipped at passage 2. Each vial contains at least 0.5x10^6 cells per ml and is delivered frozen.
Species
Pig
Source
Heart
Cell Type
Fibroblast
Disease
Normal
Quality Control
Porcine Primary Cardiac Fibroblasts are tested for negative expression of von Willebrand Factor Expression/Factor VIII, cytokeratin 18, and alpha smooth muscle actin. Porcine Primary Cardiac Fibroblasts are negative for bacteria, yeast, fungi, and mycoplasma. Cells can be expanded for 3-5 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use.
Never can cryopreserved cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

PCFs originate from pig heart tissue with their primary source being fibrous areas including the epicardium, endocardium, and myocardial interstitium. The main component cells among these cardiac fibroblasts are epicardial fibroblasts. Porcine cardiac fibroblasts provide essential support to heart structure and repair while also contributing to heart disease progression. Mechanical stability is preserved by PCFs through their production and release of extracellular matrix components including collagen. During cardiovascular conditions such as myocardial infarction and hypertension PCFs actively drive cardiac remodeling and fibrosis through secretion of pro-inflammatory cytokines and transforming growth factor beta (TGF-β). Scientists acknowledge PCFs as essential tools for investigating cardiovascular disease mechanisms because they enable research into cardiac remodeling processes as well as fibrosis and post-infarction repair. Research reveals that targeted small molecules or transcription factors successfully transform PCFs into cardiac muscle cell analogs thus providing innovative methods for heart regenerative treatments.

CircRNAs in Doxorubicin- and Myocet-Induced Cardiotoxicity in pCPCs and pCFs

Anthracycline-induced cardiotoxicity remains a major clinical challenge despite liposomal DOX (MYO) reducing myocardial drug accumulation. CircRNAs, known to sponge miRNAs and regulate pathways in cancer, are underexplored in chemotherapy-related cardiac damage.

Mester-Tonczar et al. employed a translational pig model treated with DOX or MYO, combining bulk mRNA-seq and CIRIquant for circRNA identification. Then, two candidate circRNAs (circ-MT:3033|3289 and circ-MT:3070|3478) were validated in porcine cardiac progenitor cells (pCPCs) and porcine cardiac fibroblasts (pCFs). In pCPCs, circ-MT:3033|3289 expression was significantly downregulated in MYO-treated groups versus controls and DOX-treated cells (Fig. 1A). Conversely, in pCFs, MYO and DOX treatments upregulated circ-MT:3033|3289 compared to controls (Fig. 1B). No significant changes were observed for circ-MT:3070|3478 in either cell type (Fig. 1C and D). These results suggest MYO exerts a stronger regulatory effect on circ-MT:3033|3289 than DOX. Sanger sequencing confirmed mitochondrial circRNA backsplice junctions (Fig. 2A and B).

Expression of MT-CircRNAs in cells treated with DOX and MYO in vitro.Fig. 1. In vitro expression of mt-circRNAs in DOX- and MYO-treated cells (Mester-Tonczar J, Einzinger P, et al.,2023).

Sanger sequencing verification of CircRNA Backsplice junctions in cell culture experiments.Fig. 2. The presence of backsplice junctions (BSJ) of circRNA in cell culture experiments confirmed using Sanger sequencing (Mester-Tonczar J, Einzinger P, et al.,2023).

Treatment With CHIR + FGF1 Enhances Cell Cycle Progression of Vascular Cells and Fibroblasts In Vitro

AMI mortality correlates with infarct size, as cardiomyocyte regeneration is minimal, making myocyte salvage crucial. Fan's team investigated using nanoparticles (NPs) for sustained chemical release, specifically FGF1 and CHIR99021, to promote myocardial protection and infarct size reduction.

To investigate chemical-mediated cardioprotection mechanisms, neonatal cardiomyocytes (NCMs) and vascular cells (ECs, SMCs) were treated with CHIR-FGF1-NPs. Treatment with CHIR, FGF1, or both did not affect BrdU incorporation in NCMs compared to controls. For HUVECs, CHIR + FGF1 significantly increased cell cycle markers (Ki-67, PH3, BrdU, Aurora B) compared to single treatments or controls. Similarly, HVSMCs treated with CHIR + FGF1 showed greater marker expression than single treatments. To determine the effect of CHIR and FGF1 on the cell cycle progression of fibroblasts, the porcine cardiac fibroblasts were isolated, cultured, cell cycle synchronized, and treated with CHIR + FGF1 for 24 hours and assessed again for various cell cycle–associated markers, including BrdU (S phase marker) and PH3 (M phase marker). The incorporation of BrdU and the expression pattern of PH3 are shown in Figure 3, A and B. Quantification of the percentage of vimentin+ (red, vimentin) fibroblasts demonstrated that the expression levels of both markers were significantly higher in the CHIR + FGF1–treated group compared with control groups (Fig. 3A and B).

In vitro evaluation of the cell cycle in cardiac fibroblasts.Fig. 3. Assessment of cell cycle in cardiac fibroblasts in vitro (Fan C, Oduk Y, et al., 2020).

Are cell culture media formulated the same for different cells?

The culture medium is different for different cells.

Ask a Question

Average Rating: 5.0    |    1 Scientist has reviewed this product

Authentic

Creative Bioarray's cell culture products are authentic. The process was very easy to understand and it worked flawlessly.

12 Aug 2023


Ease of use

After sales services

Value for money


Write your own review

For research use only. Not for any other purpose.